H&LS Workshop: IP Portfolio Strategy for Life Science Startups

10:00 am — 11:00 am
Monday, July 20, 2020
Virtual Event via Zoom

Topic: IP Portfolio Strategy for Life Science Startups

David Resnick, patent attorney, partner, and biotechnology practice co-leader at Nixon Peabody, will be joining us to discuss intellectual property strategies for life science startups. We will talk about constructing a robust life science IP portfolio, as well as strategies used by startups to build a moat around your business & technology in order maximize your competitive advantage. Topics will include provisional vs non-provisional patents, PCT filings, deciding when to use patents vs trade secrets, establishing freedom to operate, managing IP, leveraging licensing opportunities, and strategies for filing patents.

Speaker Bio: David Resnick is a partner in the Intellectual Property practice at Nixon Peabody and the leader of the Patent Team. He works with both startup and established life sciences companies, as well as major U.S. research institutions, to develop comprehensive patent strategies to protect their IP. His practice focuses on strategic portfolio management, patent prosecution, freedom-to-operate and associated client counseling. David has extensive experience with microbiome-related technologies, pharmacogenomics, proteomics, tissue engineering, gene therapy, and regenerative medicine.

About the Workshop Series: This series of workshops is for early-stage life science founders from the Harvard Innovation Labs ecosystem. The workshop will focus specifically on business development, commercialization strategy, and product development strategy for life sciences and healthcare markets. Topics will include prioritization of indications/applications, competitor landscape analyses, intellectual property strategy, regulatory & payer/reimbursement strategy, partnerships & alliances with industry, and venture financing & fundraising strategy. The workshop will bring together founders in an informal setting with leaders from life science startups, industry, and venture capital for group discussions on these different topics. The series will include ‘homework’ given to the founders, which will then be shared and discussed with the group as a means to gain feedback and insights into other founder’s learning experiences. The workshop series will also serve the purpose of promoting a strong sense of community among the founders, allowing them to help one another through the challenges experienced as early-stage life science founders.

H&LS Workshop: IP Portfolio Strategy for Life Science Startups
Share This